FI793533A - Foerfarande foer framstaellning av farmakologiskt aktiva histamin-h2-antagonister - Google Patents

Foerfarande foer framstaellning av farmakologiskt aktiva histamin-h2-antagonister

Info

Publication number
FI793533A
FI793533A FI793533A FI793533A FI793533A FI 793533 A FI793533 A FI 793533A FI 793533 A FI793533 A FI 793533A FI 793533 A FI793533 A FI 793533A FI 793533 A FI793533 A FI 793533A
Authority
FI
Finland
Prior art keywords
antagonister
pharmacological active
framework
pharmaceutical
active histamine
Prior art date
Application number
FI793533A
Other languages
English (en)
Inventor
Thomas Henry Brown
Robert John Ife
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of FI793533A publication Critical patent/FI793533A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
FI793533A 1978-11-13 1979-11-12 Foerfarande foer framstaellning av farmakologiskt aktiva histamin-h2-antagonister FI793533A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7844260 1978-11-13
GB7929013 1979-08-21

Publications (1)

Publication Number Publication Date
FI793533A true FI793533A (fi) 1980-05-14

Family

ID=26269556

Family Applications (1)

Application Number Title Priority Date Filing Date
FI793533A FI793533A (fi) 1978-11-13 1979-11-12 Foerfarande foer framstaellning av farmakologiskt aktiva histamin-h2-antagonister

Country Status (22)

Country Link
US (1) US4496567A (fi)
EP (1) EP0013071B1 (fi)
JP (1) JPS55500898A (fi)
AU (1) AU534802B2 (fi)
CA (1) CA1137984A (fi)
CS (1) CS214813B2 (fi)
DD (1) DD146953A5 (fi)
DE (1) DE2966413D1 (fi)
DK (1) DK298180A (fi)
ES (1) ES485912A1 (fi)
FI (1) FI793533A (fi)
GR (1) GR78338B (fi)
HU (1) HU182740B (fi)
IE (1) IE49205B1 (fi)
IL (1) IL58676A (fi)
NO (1) NO793642L (fi)
NZ (1) NZ192096A (fi)
PH (1) PH15579A (fi)
PL (1) PL126169B1 (fi)
PT (1) PT70441A (fi)
RO (1) RO78491A (fi)
WO (1) WO1980000966A1 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140129A (en) * 1979-08-21 1983-01-25 Ronald J. King 4-pyrimidone derivatives
DE3275291D1 (en) * 1981-07-24 1987-03-05 Glaxo Group Ltd Heterocyclic derivatives
US4745110A (en) * 1983-04-29 1988-05-17 Rorer Pharmaceutical Corporation Bicyclic benzenoid aminoalkylene ethers and thioethers, pharmaceutical compositions and use
GB8318638D0 (en) * 1983-07-09 1983-08-10 Smith Kline French Lab Chemical compounds
GB8320505D0 (en) * 1983-07-29 1983-09-01 Smith Kline French Lab Chemical compounds
US4772704A (en) * 1983-09-21 1988-09-20 Bristol-Myers Company 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
GB8332091D0 (en) * 1983-12-01 1984-01-11 Smith Kline French Lab Chemical compounds
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
JO1410B1 (en) * 1984-11-03 1986-11-30 سميث كلاين اند فرينش لابوراتوريز ليمتد Vehicles
JPS61155373A (ja) * 1984-12-28 1986-07-15 Yamanouchi Pharmaceut Co Ltd 新規な２−置換アミノ−４（１ｈ）−ピリミドン誘導体及びその製造法
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
EP3909449A1 (en) 2020-05-11 2021-11-17 Bisaf Spolka Z Ograniczona Odpowiedzialnoscia Protective filtering half mask

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980781A (en) * 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
GB1223686A (en) * 1967-02-24 1971-03-03 Ici Ltd Salts of pyrimidine derivatives and the use thereof as fungicides
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
IN146736B (fi) * 1975-10-02 1979-08-25 Smith Kline French Lab
US4145546A (en) * 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
US4117131A (en) * 1976-12-07 1978-09-26 Warner-Lambert Company Method of inhibiting gastric acid secretions with 2-(4-pyrimidinyl)thioacetamides
GB1604674A (en) * 1977-05-17 1981-12-16 Allen & Hanburys Ltd Aminoalkyl-benzene derivatives
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives

Also Published As

Publication number Publication date
JPS55500898A (fi) 1980-11-06
US4496567A (en) 1985-01-29
ES485912A1 (es) 1980-07-01
RO78491A (ro) 1982-02-26
EP0013071B1 (en) 1983-11-16
NO793642L (no) 1980-05-14
AU534802B2 (en) 1984-02-16
AU5272279A (en) 1980-05-22
HU182740B (en) 1984-03-28
PL126169B1 (en) 1983-07-30
GR78338B (fi) 1984-09-26
PH15579A (en) 1983-02-17
EP0013071A1 (en) 1980-07-09
DK298180A (da) 1980-07-10
DE2966413D1 (en) 1983-12-22
IL58676A0 (en) 1980-02-29
WO1980000966A1 (en) 1980-05-15
PT70441A (en) 1979-12-01
CS214813B2 (en) 1982-06-25
IE49205B1 (en) 1985-08-21
CA1137984A (en) 1982-12-21
DD146953A5 (de) 1981-03-11
PL219563A1 (fi) 1980-12-01
IE792169L (en) 1980-05-13
NZ192096A (en) 1981-11-19
IL58676A (en) 1983-07-31

Similar Documents

Publication Publication Date Title
FI65914B (fi) Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
FI790321A (fi) Foerfarande foer framstaellning av 6-substituerade tia-azafoereningar
NO153177C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater.
FI781955A (fi) Foerfarande foer framstaellning av farmakologiskt anvaendbara 1,2,3,6-tetrahydroisonikotinsyraderivater
FI781386A (fi) Farmakologiskt aktiva komponenter
NO162073C (no) Analogifremgangsmaate for fremstilling av farmakologiske aktive heterocykliske forbindelser.
BE853264A (fr) Substance pharmacologiquement active extraite de labiees
FI781490A (fi) Farmakologiskt aktiva komponenter
FI803025A (fi) Foerfarande foer framstaellning av farmakologiskt aktiva ergolinderivat
FI793533A (fi) Foerfarande foer framstaellning av farmakologiskt aktiva histamin-h2-antagonister
FI834735A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva pyridinderivat
FI784040A (fi) Foerfarande foer framstaellning av fibervals
FI792740A (fi) Anordning foer faestande av en foliehinna under vaermelimning
FI791456A (fi) Farmaceutiska foereningar
FI65794B (fi) Foerfarande foer framstaellning av bindemedel foer haeftlim
FI813198L (fi) Foerfarande foer framstaellning av farmakologiskt aktiva peptider
FI790404A (fi) Farmaceutiska sammansaettningar
FI783098A (fi) Farmakologiskt aktiva kompositioner
FI792220A (fi) Foerfarande foer framstaellning av pyrimidinfoereningar
NO780743L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner
FI834736A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva pyridinderivat
FI792476A (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva tiofenkarboxamidoalkylmerkaptaner
FI783582A (fi) Foerfarande foer framstaellning av med korsbottnar foersedda saeckar
IT1116869B (it) Derivati di n-alcheni-moranolina aventi attivita'farmacologica
FI791462A (fi) Modifierad vaetskeformig roekblandning och daerav framstaellda foedoaemneshoeljen

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SMITH KLINE & FRENCH LABORATORIES